BioAtla, Inc. (BCAB)
NASDAQ: BCAB · Real-Time Price · USD
5.00
-0.84 (-14.38%)
Apr 23, 2026, 4:00 PM EDT - Market closed
BioAtla Market Cap
BioAtla has a market cap or net worth of $8.38 million as of April 23, 2026. Its market cap has decreased by -50.51% in one year.
Market Cap
8.38M
Enterprise Value
8.76M
1-Year Change
-50.51%
Ranking
Category
Stock Price
$5.00
Market Cap Chart
Since the IPO on December 16, 2020, BioAtla's market cap has decreased from $9.78B to $8.38M, a decrease of -99.91%. That is a compound annual growth rate of -73.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 22, 2026 | 9.68M | -71.13% |
| Dec 31, 2025 | 33.51M | -2.30% |
| Dec 31, 2024 | 34.30M | -70.91% |
| Dec 29, 2023 | 117.92M | -86.61% |
| Dec 30, 2022 | 880.59M | -59.20% |
| Dec 31, 2021 | 2.16B | -40.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silo Pharma | 10.84M |
| Genprex | 10.45M |
| CalciMedica | 10.42M |
| Bolt Biotherapeutics | 9.90M |
| Evogene | 9.77M |
| Liminatus Pharma | 9.65M |
| NuCana | 9.53M |
| GridAI Technologies | 9.38M |